Aim: To study the clinical profile of ocular psoriasis and to identify features that help in the recognition and prevention of ocular morbidity and visual loss in these patients. Methods: A prospective observational study was conducted on 100 patients with psoriasis in a tertiary care, multispecialty hospital. All patients underwent systemic evaluation by the dermatologist, followed by ophthalmic evaluation comprising of visual assessment, slit lamp examination, ophthalmoscopy, Schirmer__ampersandsignrsquo;s test, tear breakup time, Rose Bengal staining and ancillary investigations such as fundus fluorescein angiography (FFA) and optical coherence tomography (OCT). Results: Among 100 patients with psoriasis, the prevalence of ophthalmic manifestation was 60%, of whom 42% were symptomatic. Ocular features were most common in scalp psoriasis and pustular psoriasis. The type and severity of ocular manifestation had a positive correlation with the duration of psoriasis. The most common ophthalmic feature was keratoconjunctivitis sicca (55%), followed by meibomitis (50%), cataract (35%), blepharitis (20%) and uveitis (5%). Uveitis had associated with psoriatic arthritis. The correlation was established using the kappa coefficient. Statistical significance was found in the conjunctival staining pattern with a p-value = 0.02. Steroid-induced glaucoma occurred in 24%. Keratoconjunctivitis sicca and corticosteroids used in the management of systemic psoriasis were found to be the most frequent causes of visual morbidity. Conclusion: Ophthalmic clinical features, signs and symptoms in psoriasis may be subtle and a complete ophthalmic evaluation is required both for early detection of ocular abnormalities and complications. A multidisciplinary approach is required to reduce ocular morbidity in the active phase of psoriasis during and after treatment in these patients.